Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/20
End: 01/31/23
Due: 01/31/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias | NCT03801889 | Abfero Pharmaceuticals, Inc | user2@example.com | None | 2020-08-31 | 2023-01-31 | 2024-01-31 | - | - | 2025-07-14 |